Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Gastroenterology
Published in: BMC Gastroenterology 1/2014

Open Access 01-12-2014 | Research article

The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli

Authors: Fabrizio Tremolaterra, Serena Gallotta, Yvonne Morra, Ennio Lubrano, Carolina Ciacci, Paola Iovino

Published in: BMC Gastroenterology | Issue 1/2014

Login to get access

Abstract

Background

Fibromyalgia Syndrome (FMS) is a frequent comorbidity in Irritable Bowel Syndrome (IBS) patients with a higher functional bowel disorder severity index (FBDSI). We tested the possibility that mild to severe IBS patients without FMS would have a graduated visceral and somatic perception, and the presence of FMS would further enhance somatic, but conversely attenuate visceral perception.
Our aim was to study visceral and somatic sensitivity in mild IBS patients and in severe IBS patients with or without FMS.

Methods

Eleven mild IBS and 19 severe IBS with and without FMS patients were studied. Somatic and visceral stimuli were applied in each patient by means of electrical stimulations at active and control sites and by means of an electronic barostat in the rectum. Thresholds for discomfort and perception cumulative scores were measured.

Results

Mild and severe IBS patients without FMS demonstrated a significantly lower somatic perception cumulative score than severe IBS patients with FMS at active site. Conversely only severe IBS patients without FMS had significantly lower visceral thresholds for discomfort than mild IBS patients and severe IBS patients with FMS.

Conclusions

The presence of co-existing FMS or greater FBDSI affects somatic and visceral perception in a graded fashion across IBS patients.
Appendix
Available only for authorised users
Literature
1.
Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology. 2002, 123: 2108-2131. 10.1053/gast.2002.37095. PMID: 12454866 – doi:10.1053/gast.2002.37095CrossRefPubMed
2.
Whitehead WE, Palsson O, Jones KR: Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002, 122: 1140-1156. 10.1053/gast.2002.32392. PMID: 11910364 – doi:10.1053/gast.2002.32392CrossRefPubMed
3.
Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, Mönnikes H: Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008, 64: 573-582. 10.1016/j.jpsychores.2008.02.021. PMID: 18501257 – doi:10.1016/j.jpsychores.2008.02.021CrossRefPubMed
4.
Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, Fich A, Buskila D: Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications. Am J Gastroenterol. 1999, 94: 3541-6. 10.1111/j.1572-0241.1999.01643.x. PMID: 10606316 – doi:10.1111/j.1572-0241.1999.01643.xCrossRefPubMed
5.
Veale D, Kavanagh G, Fielding JF, Fitzgerald O: Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenic process. Br J Rheumatol. 1991, 30: 220-2. 10.1093/rheumatology/30.3.220. PMID: 2049586 doi:10.1016/j.jpsychores.2008.02.021CrossRefPubMed
6.
Barton A, Whorwell PJ, Marshall D: Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol. 1999, 94: 1898-901. 10.1111/j.1572-0241.1999.01146.x. PMID: 10406256 – doi:10.1111/j.1572-0241.1999.01146.xCrossRefPubMed
7.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The american college of rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicentrum criteria committee. Arthritis Rheum. 1990, 33: 160-72. 10.1002/art.1780330203. PMID: 2306288 – doi:10.1002/art.1780330203CrossRefPubMed
8.
Sperber AD, Carmel S, Atzmon Y, Weisberg I, Shalit Y, Neumann L, Fich A, Friger M, Buskila D: Use of the functional bowel disorder severity index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol. 2000, 95 (4): 995-998. 10.1111/j.1572-0241.2000.01977.x. PMID: 10763949 – doi:10.1111/j.1572-0241.2000.01977.xCrossRefPubMed
9.
Lubrano E, Iovino P, Tremolaterra F, Parsons WJ, Ciacci C, Mazzacca G: Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Colorectal Dis. 2001, 16: 211-5. 10.1007/s003840100299. PMID: 11515679 - doi:10.1007/s003840100299CrossRefPubMed
10.
Chang L, Mayer EA, Johnson T, Fitzgerald LZ, Naliboff B: Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain. 2000, 84 (2–3): 297-307. PMID: 10763949 - doi:10.1016/S0304-3959(99)00215-8CrossRefPubMed
11.
Caldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, Balatsinou C, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M: Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am J Gastroenterol. 2006, 101: 2782-9. 10.1111/j.1572-0241.2006.00823.x. PMID: 17227524 - doi:10.1111/j.1572-0241.2006.00823.xCrossRefPubMed
12.
Verne GN, Robinson ME, Price DD: Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain. 2001, 93: 7-14. 10.1016/S0304-3959(01)00285-8. PMID: 11406333 – doi:10.1016/S0304-3959(01)00285-8CrossRefPubMed
13.
Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN: Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain. 2007, 23: 323-30. 10.1097/AJP.0b013e318032e496. PMID: 17449993 - doi:10.1097/AJP.0b013e318032e496CrossRefPubMed
14.
Iovino P, Tremolaterra F, Consalvo D, Sabbatini F, Mazzacca G, Ciacci C: Perception of electrocutaneous stimuli in irritable bowel syndrome. Am J Gastroenterol. 2006, 101: 596-603. 10.1111/j.1572-0241.2006.00414.x. PMID: 16464229 - doi:10.1111/j.1572-0241.2006.00414.xCrossRefPubMed
15.
Piché M, Arsenault M, Poitras P, Rainville P, Bouin M: Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain. 2010, 148 (1): 49-58. 10.1016/j.pain.2009.10.005.CrossRefPubMed
16.
Piché M, Bouin M, Arsenault M, Poitras P, Rainville P: Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience. 2011, 195: 166-175. doi:S0306-4522(11)00982-1CrossRefPubMed
17.
Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC: Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007, 19 (1): 62-88.CrossRefPubMed
18.
Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M: Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology. 2007, 133 (4): 1113-23. 10.1053/j.gastro.2007.07.024. Epub 2007 Jul 25. PMID: 17919487 - doi:10.1053/j.gastro.2007.07.024CrossRefPubMed
19.
Kanazawa M, Palsson OS, Thiwan SI, Turner MJ, van Tilburg MA, Gangarosa LM, Chitkara DK, Fukudo S, Drossman DA, Whitehead WE: Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol. 2008, 103 (10): 2550-61. 10.1111/j.1572-0241.2008.02066.x. PMID: 18684175 doi:10.1111/j.1572-0241.2008.02066.xCrossRefPubMed
20.
Poitras P, Riberdy Poitras M, Plourde V, Boivin M, Verrier P: Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002, 47: 914-920. 10.1023/A:1014729125428.CrossRefPubMed
21.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130: 1480-1491. 10.1053/j.gastro.2005.11.061. PMID: 16678561 - doi:10.1053/j.gastro.2005.11.061CrossRefPubMed
22.
Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, Read NW, Babbs C, Barreiro M, Bank L, Whitehead WE, Marvin M, Schuster MM, Guthrie EA: Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995, 40: 986-995. 10.1007/BF02064187. PMID: 7729289 – doi:10.1007/BF02064187CrossRefPubMed
23.
Iovino P, Tremolaterra F, Boccia G, Miele E, Ruju FM, Staiano A: Irritable bowel syndrome in childhood: visceral hypersensitivity and psychosocial aspects. Neurogastroenterol Motil. 2009, 21: 940-e74. 10.1111/j.1365-2982.2009.01303.x. PMID: 19368655 - doi:10.1111/j.1365-2982.2009.01303.xCrossRefPubMed
24.
Iovino P, Azpiroz F, Domingo E, Malagelada J-R: The sympathetic nervous system modulates perception and reflex responses to gut distension in humans. Gastroenterology. 1995, 108: 680-686. 10.1016/0016-5085(95)90439-5. PMID: 7875470 - doi:10.1016/0016-5085(95)90439-5CrossRefPubMed
25.
Iovino P, Valentini G, Ciacci C, De Luca A, Tremolaterra F, Sabbatini F, Tirri E, Mazzacca G: Proximal stomach function in systemic sclerosis. Relationship with autonomic nerve function. Dig Dis Sci. 2001, 46: 723-730. 10.1023/A:1010779729184. PMID: 11330404 – doi:10.1023/A:1010779729184CrossRefPubMed
26.
Tremolaterra F, Pascariello A, Gallotta S, Ciacci C, Iovino P: Colonic gas transit in patients with bloating: the effect of an electromechanical stimulator of the abdominal wall. Tech Coloproctol. 2013, 17 (4): 405-410. 10.1007/s10151-012-0951-1. PMID: 23207715 - doi:10.1007/s10151-012-0951-1CrossRefPubMed
27.
Distrutti E, Salvioli B, Azpiroz F, Malagelada JR: Rectal function and bowel habit in irritable bowel syndrome. Am J Gastroenterol. 2004, 99 (1): 131-7. 10.1046/j.1572-0241.2003.04012.x.CrossRefPubMed
28.
The Working Team of Glaxo-Wellcome Research, UK, Whitehead WE, Delvaux M: Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci. 1997, 42 (2): 223-41. 10.1023/A:1018885028501.CrossRef
29.
Accarino AM, Azpiroz F, Malagelada J-R: Symptomatic responses to stimulation of sensory pathways in the jejunum. Am J Physiol. 1992, 263: G673-G677.PubMed
30.
Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, Verrier P, Poitras P: Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002, 122: 1771-1777. 10.1053/gast.2002.33601. PMID: 12055583 – doi:10.106/0016-5085(95)90439-5CrossRefPubMed
31.
Ludidi S, Conchillo JM, Keszthelyi D, Van Avesaat M, Kruimel JW, Jonkers DM, Masclee AA: Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff. Neurogastroenterol Motil. 2012, 24 (8): 729-33. 10.1111/j.1365-2982.2012.01926.x. e345-6. PMID: 22591192 - doi:10.1111/j.1365-2982.2012.01926.xCrossRefPubMed
32.
Accarino AM, Azpiroz F, Malagelada J-R: Selective dysfunction of mechanosensitive intestinal afferents in the irritable bowel syndrome. Gastroenterology. 1995, 108 (3): 636-643. 10.1016/0016-5085(95)90434-4.CrossRefPubMed
33.
Tunks E, Crook J, Norman G, Kalaher S: Tender points in fibromyalgia. Pain. 1988, 34: 11-19. 10.1016/0304-3959(88)90176-5. PMID: 3165524 – doi:10.1016/0304-3959(88)90176-5CrossRefPubMed
34.
Kosek E, Ekholm J, Hansson P: Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain. 1995, 63: 335-339. 10.1016/0304-3959(95)00061-5. PMID: 8719534 - doi:10.1016/0304-3959(95)00061-5CrossRefPubMed
35.
Bendtsen L, Norregaard J, Jensen R, Olesen J: Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum. 1997, 40: 98-102. 10.1002/art.1780400114. PMID: 9008605 - doi:10.1002/art.1780400114CrossRefPubMed
36.
Kim SE, Chang L: Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?. Neurogastroenterol Motil. 2012, 24 (10): 895-913. 10.1111/j.1365-2982.2012.01993.x. Epub 2012 Aug 2. PMID: 22863120 - doi:10.1111/j.1365-2982.2012.01993.xCrossRefPubMed
37.
Zhou Q, Fillingim RB, Riley JL, Malarkey WB, Verne GN: Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain. 2010, 148 (3): 454-461. 10.1016/j.pain.2009.12.005. PMDI: 20074857- doi:10.1016/j.pain.2009.12.005CrossRefPubMedPubMedCentral
38.
Drossman DA, Chang L, Bellamy N, Gallo-Torres HE, Lembo A, Mearin F, Norton NJ, Whorwell P: Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol. 2011, 106 (10): 1749-59. 10.1038/ajg.2011.201. PMID: 21747417 - doi:10.1038/ajg.2011.201CrossRefPubMed
39.
Verne GN, Robinson ME, Vase L, Price DD: Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain. 2003, 105 (1–2): 223-230.CrossRefPubMed
40.
Staud R, Nagel S, Robinson ME, Price DD: Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double blind, placebo-controlled study. Pain. 2009, 145 (1–2): 96-104. PMID: 19540671 doi:10.1016/j.pain.2009.05.020CrossRefPubMedPubMedCentral
41.
Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A: Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut. 2004, 53 (11): 1595-1601. 10.1136/gut.2003.028514.CrossRefPubMedPubMedCentral
42.
Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain. 1997, 70 (1): 41-51. 10.1016/S0304-3959(96)03295-2.CrossRefPubMed
43.
Lautenbacher S, Rollman GB: Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997, 13 (3): 189-196. 10.1097/00002508-199709000-00003.CrossRefPubMed
44.
Julien N, Goffaux P, Arsenault P, Marchand S: Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005, 114 (1–2): 295-302.CrossRefPubMed
45.
Wilder-Smith CH: The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut. 2011, 60: 1589-1599. 10.1136/gutjnl-2011-300253. doi:10.1136/gutjnl-2011-300253CrossRefPubMed
46.
Mayer EA, Bradesi S, Chang L, Spiegel BMR, Bueller JA, Naliboff BD: Functional GI disorders: from animal models to drug development. Gut. 2008, 57 (3): 384-404. 10.1136/gut.2006.101675. doi:10.1136/gut.2006.101675CrossRefPubMed
47.
Keszthelyi D, Troost FJ, Simrén M, Ludidi S, Kruimel JW, Conchillo JM, Masclee AA: Revisiting concepts of visceral nociception in irritable bowel syndrome. Eur J Pain. 2012, 16: 1444-1454. 10.1002/j.1532-2149.2012.00147.x. doi:10.1002/j.1532-2149.2012.00147.xCrossRefPubMed
48.
Crook J, Rideout E, Browne G: The prevalence of pain complaints in a general population. Pain. 1984, 18: 299-314. 10.1016/0304-3959(84)90824-8. PMID: 6728496 – doi:10.1016/0304-959(84)90824-8CrossRefPubMed
49.
Berman S, Munakata J, Naliboff BD, Chang L, Mandelkern M, Silverman D, Kovalik E, Mayer EA: Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain. 2000, 4 (2): 157-72. 10.1053/eujp.2000.0167. PMID: 10957697- doi:10.1053/eujp.2000.0167CrossRefPubMed
50.
Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA: Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology. 2003, 124: 1738-1747. 10.1016/S0016-5085(03)00400-1. PMID: 12806606 – doi:10.1016/S0016-5085(03)00400-1CrossRefPubMed
51.
Houghton LA, Lea R, Jackson N, Whorwell PJ: The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut. 2002, 50: 471-474. 10.1136/gut.50.4.471. PIMID: 11889064 – doi:10.1136/gut.50.4.471CrossRefPubMedPubMedCentral
52.
Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK: Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006, 26: 5777-5785. 10.1523/JNEUROSCI.5223-05.2006. PMID: 16723535 – doi:10.1523/JNEUROSCI.5223-05.2006CrossRefPubMedPubMedCentral
53.
Cervero F: Visceral versus somatic pain: similarities and differences. Dig Dis. 2009, 27 (1): 3-10. 10.1159/000268115. PMID: 20203491 – doi:10.1159/000268115CrossRefPubMed
Metadata
Title
The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli
Authors
Fabrizio Tremolaterra
Serena Gallotta
Yvonne Morra
Ennio Lubrano
Carolina Ciacci
Paola Iovino
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2014
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-14-182

Other articles of this Issue 1/2014

BMC Gastroenterology 1/2014 Go to the issue

Research article

Initial presentations and final outcomes of primary pyogenic liver abscess: a cross-sectional study

Research article

A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation

Research article

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)

Research article

Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity

Research article

Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations

Research article

Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits